Forum for Science, Industry and Business
Sponsored by:     Siemens  n-tv 
Search our Site:

Topic (optional):

 

Home Reports Health and Medicine Content

Pacemakers and defibrillators for the survival of patients suffering from heart insufficiency

next article
07.06.2005

 


Studies recently carried out at the University Hospital of the University of Navarra show that cardiac resynchronisation therapy using pacemakers and defibrillators improves the survival and quality of life of patients suffering from heart insufficiency and disorders of the blood-flow system.



Cardiac resynchronisation

One of the advances for heart insufficiency developed over the past few years has been the incorporation of biventricular pacemakers and defibrillators. Known as cardiac resynchronisation therapy, their implantation provides the advantage of increasing the performance of the heart in a number of patients with this pathology. In some cases, the heart insufficiency not only involves a loss of contractile force, but also an alteration in the synchronisation of the heart. That is to say, contraction occurs with little force and, moreover, in a disordered manner and, thus, the heart’s performance or yield is notably worsened.

With cardiac resynchronisation the desynchronisation of the heart contractions caused by electrical pulse disorders are minimised, and so the heart recovers part of its normal function. This results in a decrease in the symptoms, especially fatigue, and in a greater survival rate for patients.

Cardiac resynchronisation therapy can be carried out in an isolated manner (with a specific pacemaker) or with a defibrillator, which also has the ability to treat the cardiac arrhythmias that can occur with some of these patients. In some cases the implantation is began in a conventional manner through the right auricle and ventricle, the left ventricle being subsequently accessed through the coronary venous system, and up to three electrodes implanted. The procedure is carried out under local anaesthetic, lasts between one and two hours and the postoperative stage is rapid, thus enabling the patient to be released in one or two days.

Irati Kortabitarte | Source: alphagalileo
Further information: www.basqueresearch.com

next article

More articles from Health and Medicine:

nachricht Polyphenols and polyunsaturated fatty acids boost the birth of new neurons
25.11.2009 | Universitat Autonoma de Barcelona

nachricht Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps
24.11.2009 | Johns Hopkins Medical Institutions

All articles from Health and Medicine >>>

B2B Search

Product / Service
Company / Organisation

Latest News

First black holes may have incubated in giant, starlike cocoons

25.11.2009 | Physics and Astronomy

KfW issues its first ever 7 year Euro-Benchmark

25.11.2009 | Business and Finance

Intelligence inside metal components

25.11.2009 | Information Technology

VideoLinks
More VideoLinks >>>

Event News

Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients

20.11.2009 | Event News

'Golden Age' for clinical psychology in Northern Ireland

20.11.2009 | Event News

New Perspectives in Marine Anti-Fouling Research

11.11.2009 | Event News